1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Neoplasm, Nerve Tissue: new trials by email Literature Review of Neoplasm, Nerve Tissue trials Research Report on Neoplasm, Nerve Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects DNX-2401, pembrolizumab - Brain Cancer, Brain Neoplasm | Phase 2 | Completed | DNAtrix, Inc. | 49 | 2016-10-06 | 2021-07-15 |
Brain Neoplasms (1) · Disease (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Neoplasms (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Neuroectodermal Tumors (1)
Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Nervous System Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Antibodies, Monoclonal (1) · Oncolytic Virotherapy (1) · pembrolizumab (1)
DNAtrix, Inc. (1)
Canada (1) · United States (1)
Nancy Gady, BS (1)